InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
其他已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Discover the complete record of transactions filed by Nolet Chris. Insider active across 3 companies, notably Revance Therapeutics, Inc.. Aggregated, 8 filings have been published. Activity tracked since 5 May 2021. The latest transaction was disclosed on 4 February 2025 (U). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Nolet Chris
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报8 总计
28,606 股@ US$3.65100.0% 占其流量Common StockSEC:0000950170-25-015339:0
15,000 股0Common StockSEC:0001479290-24-000088:0
3,534 股0Common StockSEC:0001479290-23-000062:0
36,497 股0Common StockSEC:0001493152-23-001628:0
32,500 股0Voting Common StockSEC:0001213900-22-063938:0
50,900 股0Common StockSEC:0001493152-22-027578:0
6,059 股0Common StockSEC:0001479290-22-000063:0
4,013 股0Common StockSEC:0001479290-21-000112:0
8 条申报中的 8 条
About Nolet Chris
Nolet Chris is a declarant and serves as Director at Revance Therapeutics, Inc., POLARITYTE, INC. and Jasper Therapeutics, Inc. The record covers 9 filings in total, all within the recent sample, from 2021-05-07 to 2025-02-06. The modal transaction nature is Attribution, and the buy and sell amounts shown for this sample are 0 and 0; among the top filings is a 2025-02-06 filing at Revance Therapeutics, Inc. for EUR 101102.036576322.
